"Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes"

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ultra‐rapid BioChaperone Lispro improves postprandial blood glucose excursions vs insulin lispro in a 14‐day crossover treatment study in people with type 1 diabetes

To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra‐rapid formulation of insulin lispro (LIS) in people with type 1 diabetes. Click to show full abstract

To investigate the safety and efficacy of BioChaperone Lispo (BCLIS), an ultra‐rapid formulation of insulin lispro (LIS) in people with type 1 diabetes.

Keywords: ultra rapid; biochaperone; people type; insulin lispro; type diabetes; diabetes ultra

Journal Title: Diabetes
Year Published: 2018

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
1

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended